Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 26 Prostatic Neoplasms 24 Breast Neoplasms 17 Carcinoma, Non-Small-Cell Lung 15 Multiple Myeloma 14 Sarcoma 12 Leukemia, Myeloid, Acute 12 Glioma 12 Lymphoma, Non-Hodgkin 10 Carcinoma, Hepatocellular 10 Wilms Tumor 9 Osteosarcoma 9 Colorectal Neoplasms 9 Rectal Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Ovarian Neoplasms 8 Neuroblastoma 8 Neoplasm Metastasis 8 Myelodysplastic Syndromes 8 Rhabdomyosarcoma 7 Rhabdoid Tumor 7 Pancreatic Neoplasms 7 Mouth Neoplasms 7 Medulloblastoma 7 Hepatoblastoma 7 Neuroectodermal Tumors, Primitive, Peripheral 6 Melanoma 6 Lymphoma 6 Histiocytosis, Langerhans-Cell 6 Head and Neck Neoplasms 6

Interventions

Surveys and Questionnaires 5 pazopanib 3 Erlotinib Hydrochloride 3 Cetuximab 3 Vorinostat 2 Oxaliplatin 2 Bevacizumab 2 Azacitidine 2 temsirolimus 1 satraplatin 1 ridaforolimus 1 ixazomib 1 X-Rays 1 Videotape Recording 1 Valproic Acid 1 Trastuzumab 1 Sugars 1 Sorafenib 1 Platinum 1 Pemetrexed 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Lenalidomide 1 Lapatinib 1 LY 2275796 1 Injections, Subcutaneous 1 Fluorouracil 1 Everolimus 1 Curcumin 1 Crizotinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Cancers × X-Rays × Clear all

NCT01432119 2013-04-09

Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib

M.D. Anderson Cancer Center

Phase 1 Withdrawn

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡